{"id":"NCT03616964","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-08-02","primaryCompletion":"2021-09-24","completion":"2021-10-20","firstPosted":"2018-08-06","resultsPosted":"2022-11-23","lastUpdate":"2022-11-23"},"enrollment":778,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Systemic Lupus Erythematosus"],"interventions":[{"type":"DRUG","name":"Baricitinib","otherNames":["LY3009104"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"2 milligram (mg) Baricitinib","type":"EXPERIMENTAL"},{"label":"4 mg Baricitinib","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).","primaryOutcome":{"measure":"Percentage of Participants Achieving a Systemic Lupus Erythematosus Responder Index 4 (SRI-4) Response (4 mg Baricitinib)","timeFrame":"Week 52","effectByArm":[{"arm":"Placebo","deltaMin":45.6,"sd":null},{"arm":"4 mg Baricitinib","deltaMin":47.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.711"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":5},"locations":{"siteCount":159,"countries":["United States","Argentina","Chile","Colombia","France","India","Italy","Japan","Philippines","Poland","Romania","Serbia","South Africa","South Korea","Spain"]},"refs":{"pmids":["40305472","36848919","33687069"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/MnvCKtj7wIG0g4Wo2ugIc"]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":256},"commonTop":["Urinary tract infection","Headache","Nasopharyngitis","Upper respiratory tract infection","Diarrhoea"]}}